/ FDA
/ Market Analysis
Why Did Outlook Therapeutics (OTLK) Shares Crash Today?
Outlook Therapeutics stock crashed 70% in premarket after the FDA rejected its wet AMD drug application, citing insufficient efficacy evidence despite previous ...
August 28, 2025
Ars Pharmaceuticals Shares Hit All-Time Low as FDA Rejects EpiPen Alternative
Shares of drugmaker Ars Pharmaceuticals crashed over 57% after FDA disapproved its EpiPen alternative.
September 20, 2023
Push for Novel COVID-19 Treatment Leads to Stock Market Rally
How will the rally end?
August 24, 2020
Back to 
